Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Blijenberg

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|November 1, 1986
[Determination of the urinary albumin excretion in the early case-finding of nephropathy in patients with diabetes mellitus]B H Wolffenbuttel, A W van Toorenenbergen, B G Blijenberg, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|August 1, 1982
The determination of spinal fluid protein: an attempt at standardizationB G Blijenberg, E A Hische, H H Kamp, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|July 1, 1994
Improvements in creatinine methodology: a critical assessmentB G Blijenberg, H J Brouwer, T J Kuller, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|June 1, 1993
Calibrators and control samples for bilirubinometersB G Blijenberg, G Brügmann, W J Geilenkeuser, et al.
Clinical Biochemistry|January 19, 2000
New developments in the standardization of total prostate-specific antigenB G Blijenberg, B N Storm, B D Van Zelst, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Disease monitoring by the tumour markers cyfra 21.1 and TPA in patients with non-small cell lung cancerA van der Gaast, T C Kok, G S Kho, et al.
The Journal of Urology|June 1, 1997
The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general populationC H Bangma, J B Rietbergen, R Kranse, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 22, 1989
[The effect of immunoscintigraphy with monoclonal antibodies on assays of hormones and tumor markers. This is not the end of the matter!]J A Janssen, P J Blankestijn, R Docter, et al.
BJU International|October 27, 2001
Discordant performance of assays for free and total prostate-specific antigen in relation to the early detection of prostate cancerB G Blijenberg, G Yurdakul, B D Van Zelst, et al.
British Journal of Cancer|March 1, 1994
Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1A van der Gaast, C H Schoenmakers, T C Kok, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Nederlands Tijdschrift Voor Geneeskunde|November 1, 1986
[Determination of the urinary albumin excretion in the early case-finding of nephropathy in patients with diabetes mellitus]B H Wolffenbuttel, A W van Toorenenbergen, B G Blijenberg, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|August 1, 1982
The determination of spinal fluid protein: an attempt at standardizationB G Blijenberg, E A Hische, H H Kamp, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|July 1, 1994
Improvements in creatinine methodology: a critical assessmentB G Blijenberg, H J Brouwer, T J Kuller, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|June 1, 1993
Calibrators and control samples for bilirubinometersB G Blijenberg, G Brügmann, W J Geilenkeuser, et al.
Clinical Biochemistry|January 19, 2000
New developments in the standardization of total prostate-specific antigenB G Blijenberg, B N Storm, B D Van Zelst, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Disease monitoring by the tumour markers cyfra 21.1 and TPA in patients with non-small cell lung cancerA van der Gaast, T C Kok, G S Kho, et al.
The Journal of Urology|June 1, 1997
The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general populationC H Bangma, J B Rietbergen, R Kranse, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 22, 1989
[The effect of immunoscintigraphy with monoclonal antibodies on assays of hormones and tumor markers. This is not the end of the matter!]J A Janssen, P J Blankestijn, R Docter, et al.
BJU International|October 27, 2001
Discordant performance of assays for free and total prostate-specific antigen in relation to the early detection of prostate cancerB G Blijenberg, G Yurdakul, B D Van Zelst, et al.
British Journal of Cancer|March 1, 1994
Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1A van der Gaast, C H Schoenmakers, T C Kok, et al.
Pageof 8